Detailed Scientific Programme

XXIX WORLD CONGRESS OF THE INTERNATIONAL UNION OF ANGIOLOGY

SCIENTIFIC PROGRAMME*

*Subject to change

18:00 – 20:00 Opening Ceremony Hall 1
Chairs: TBC
Welcome from the Presidents
Honorary membership announcements
IUA fellowship certificates

XXVIII CONGRESS OF THE MEDITERRANEAN LEAGUE OF ANGIOLOGY AND VASCULAR SURGERY

08:00 – 09:30 Effects of the post implantation syndrome: Myth or reality? Hall 1
Chairs: N. Angelides & C. Liapis
08:00 – 08:15 Post implantation syndrome following EVAR – A. Giannoukas
08:15 – 08:30 Post implantation syndrome following TEVAR – J. Kakisis
08:30 – 08:45 Cardiac effects of TEVAR and EVAR – T. Giannakopoulos
08:45 – 09:00 The Achilles heel: From systemic effects of inflammation and biophysics to endoleaks and late ruptures.
Why EVAR fails and how to prevent and treat late complications? – J. Fernandes e Fernandes
09:00 – 09:15 Newly diagnosed arterial disease and sub-clinical target organs damage – S. Novo
09:15 – 09:30 Diagnostic tools in detection of preclinical and clinical lower extremity artery disease – P. Poredos

XXXVII CONGRESS OF THE ITALIAN SOCIETY FOR VASCULAR INVESTIGATION

08:00 – 09:30 Up to date in chronic venous disease Hall 2
Chairs: T. A. Baroncelli & F. Magnoni
08:00 – 08:15 Measuring the quality of life of patients with varicose vein disease – D. Radu
08:15 – 08:30 Superficial venous thrombosis: How can we treat? – A. Santoliquido
08:30 – 08:45 Venous symptoms: What are they and how can we be sure? – E. Diaco
08:45 – 09:00 3D imaging: New step forward for ultrasound guide sclerotherapy with foam? – M. Sica
09:00 – 09:15 The point on endovascular treatments – A. Zielinski
09:15 – 09:30 Low concentration sclerotherapy (Casoni’s method) and systemic effects on cytokines and immunoglobulins – P. Casoni

INTERNATIONAL UNION OF ANGIOLOGY & ITALIAN SOCIETY FOR MICROCIRCULATION

08:00 – 09:30 Microcirculation and vascular disease Hall 3
Chairs: C. Allegra & P. Carpentier
08:00 – 08:15 The ethylic microangiopathy – S. Bilancini
08:15 – 08:30 Venous control of microcirculation – D. Onorati
08:30 – 08:45 The erythromelalgia – P. E. Mollo
08:45 – 09:00 The livedo – M. Lucchi
09:00 – 09:15 The hyperoxia model. A novel approach to study microcirculation – H. Silva
09:15 – 09:30 Studying the effect of age in human microcirculatory adaptation and integration sensitivity – C. Rocha
09:30 – 11:00 PAD, CLI, and no-option CLI Hall 1
Chairs: N. Angelides & P. L. Antignani
09:30 – 09:45 Secondary prevention of PAD – P. Poredos
09:45 – 10:00 The use of a nine-step therapeutic ladder in PAD – N. Angelides
10:00 – 10:15 PAD and CLI in hospital admissions in Portugal. The impact of endovascular repair. What is required for adequate selection? – J. Fernandes e Fernandes
10:15 – 10:30 Endovascular treatment in PAD and CLI. When and how? – E. Hussein
10:30 – 10:45 Open surgery in PAD and CLI- When it fits? – C. Liapis
10:45 – 11:00 The role of stem cells in no-option CLI – N. Angelides

EUROPEAN VENOUS FORUM

09:30 – 11:00 Controversial studies and trials Hall 2
Chairs: J. Fareed & A. Nicolaides
09:30 – 09:45 Thrombolysis: ATTRACT and other studies – N. Baekgaard
09:45 – 10:00 DOAC antidote trials – J. Fareed
10:00 – 10:15 C0s-hypotonic phlebopathy? The acireale study – A. Nicolaides
10:15 – 10:30 Compression for the prevention of PTS – G. Mosti
10:30 – 10:45 Can we prevent PTS? – P. Prandoni
10:45 – 11:00 Discussion

EUROPEAN SOCIETY OF VASCULAR MEDICINE & CENTRAL EUROPEAN VASCULAR FORUM

09:30 – 11:00 Advances in the treatment of peripheral arterial diseases Hall 3
Chairs: R. Avram & S. Novo
09:30 – 09:50 Thromboangioitis obliterans – what do we know 110 years after the description of the disease – Leo Buerger – V. Stvrtinova
09:50 – 10:10 Old and new risk factors for peripheral arterial disease – M. Kozak
10:10 – 10:30 Peripheral arterial disease and air pollution: Risks of acute limb ischemia – J. J. Belch
10:30 – 10:45 Indications for femoro-popliteal surgical revascularization – M. Szostek
10:45 – 11:00 Medical therapy in peripheral arterial disease – L. Aluigi
11:00 – 11:30 Keynote Lecture Hall 1
Chair: P. L. Antignani
11:00 – 11:30 Mediterranean League of Angiology and Vascular Surgery: Thirty years of life – N. Angelides
11:00 – 13:00 Venous thromboembolism – Update 2020 Hall 2
Chairs: A. Tafur & C. Lattimer
11:00 – 11:15 VTE: A global problem and a prevention opportunity – A. Tafur
11:15 – 11:30 VTE prophylaxis in the medically ill: What is new and where are we going? – E. Ramacciotti
11:30 – 11:45 Fibrinolysis and surgical treatment for venous thromboembolism – C. Lattimer
11:45 – 12:00 VTE treatment extensions: Treatment for how long? – G. Palareti
12:00 – 12:15 VTE prophylaxis in major orthopaedic surgery: What’s new and what has changed? – E. Ramacciotti
12:15 – 12:30 Cancer-associated thrombosis: News in prevention and treatment – A. Tafur
12:30 – 12:45 An update on international consensus on DVT management – A. Nicolaides
12:45 – 13:00 Invited discussion

INTERNATIONAL UNION OF ANGIOLOGY

11:00 – 13:00 News in angiology from the world Hall 3
Chairs: D. Onorati & A. Scuderi
11:00 – 11:20 Great saphenous vein reflux treatment in patiens with femoral valve incompetence:
The excluded saphenous vein technique (ESVT) – M. Pagano
11:20 – 11:40 What is the best method for treating the patients with varicose veins? – E. Buturrini
11:40 – 12:00 Pelvic congestion syndrome: An unknown pathology – L. Altarazy
12:00 – 12:20 Anticoagulation after PCI in AF patients – E. Ramaciotti
12:20 – 12:40 Results so far of a detailed questionnaire on the mediterranean diet monitored by the Mediterranean League of Angiology and Vascular Surgery – N. Angelides
12:40 – 13:00 Novel targets for antithrombotic therapy: Role of factor XIa inhibition and upcoming clinical trials – E. Ramaciotti

INTERNATIONAL UNION OF ANGIOLOGY

11:30 – 12:30 Optimal medical therapy in patients with asymptomatic stenoses of carotid and lower extremity arteries Hall 1
Chairs: L. Aluigi & J. Pitha
11:30 – 12:00 Asymptomatic astherosclerotic carotid and femoral plaques: Can we calculate the risk and how low can it be reduced by lipid lowering therapy – A. Nicolaides
12:00 – 12:30 How genetics can improve early diagnosis and therapy in patients with asymptomatic peripheral artery disease: Results from “Genetica Amica” project – A. V. Gaddi
12:30 – 13:00 Keynote Lecture Hall 1
Chair: R. Simkin
12:30 – 13:00 Heparin and related drugs beyond 2020 – J. Fareed & W. Jeske
13:00 – 14:00 BREAK

XXXVII CONGRESS OF THE ITALIAN SOCIETY FOR VASCULAR INVESTIGATION

14:00 – 15:30 News in instrumental diagnostics and management of complex vascular disease Hall 1
Chairs: L. Aluigi & G. Failla
14:00 – 14:15 Eco-color-Doppler 3D for the study of carotid plaque – G. Varetto
14:15 – 14:30 Elastosonography: Where and when – R. Parisi
14:30 – 14:45 The hybrid room in modern “aorta centres” – M. Gargiulo
14:45 – 15:00 Updates in capillaroscopy – P. Carpentier
15:00 – 15:15 Venous mapping: The need of standard tool – M. De Maeseneer
15:15 – 15:30 Are the current methods of the venous outcome assessments sufficient? – C. Lattimer

LATIN AMERICAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY & LATIN AMERICAN VENOUS FORUM & BRAZILIAN SOCIETY OF PHLEBOLOGY AND LYMPHOANGIOLOGY

14:00 – 15:30 Controversies, up to date and what’s new in Latin American Phlebology Hall 2
Chairs: C. Carvalho & R. Simkin
14:00 – 14:15 Body dysmorphic syndrome in C1 patients – J. H. Ulloa
14:15 – 14:30 What is the limit for sclerotherapy for the treatment of varicose veins? – A. Scuderi
14:30 – 14:45 Venous trauma of the lower limbs. Diagnosis and surgical treatment – C. Simkin
14:45 – 15:00 Is the surgery of varicose veins current or is something from the past? – P. Komlos
15:00 – 15:15 Klippel Trenaunay syndrome. Global treatment – R. Simkin
15:15 – 15:30 Low flow malformations – A. Molina
14:00 – 15:00 Free Communications of IUA Youth Committee Hall 3
Chairs: D. H. Ji & N. Troisi
14:00 – 14:10 PREVALENCE AND PREDICTIVE VALUE OF HIGH ON-TREATMENT PLATELET REACTIVITY TO ASPIRIN IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE TREATED WITH PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY – M. Juszynski
14:10 – 14:20 RNA SEQUENCING REVEALS POTENTIAL PROTEASE ZYMOGRAPHY IN MICE WITH ABDOMINAL AORTIC ANEURYSM – H. Zhang
14:20 – 14:30 PARALLEL GRAFT TECHNIQUE FOR URGENT TREATMENT OF COMPLEX AORTIC ANEURYSMS – L. F. Rinaldi
14:30 – 14:40 3D PRINTING AND CUSTOMIZED PRE-FENESTRATION AND INNER-OUTER BRANCHED STENT GRAFT FOR THE TREATMENT FOR THORACOABDOMINAL AORTIC DISEASES – Z. Liu
14:40 – 14:50 A 14-YEAR SINGLE-CENTER REVIEW OF INFLAMMATORY ABDOMINAL AORTIC ANEURYSM REPAIR – C. Pigozzi
14:50 – 15:00 COMPARISON BETWEEN ENDOVASCULAR AND OPEN SURGICAL REPAIR OF POPLITEAL ARTERY ANEURYSM – R. Abu Saleh
15:00 – 16:00 Free Communications of IUA Youth Committee Hall 3
Chairs: R. G. Abu Saleh & D. L. Li
15:00 – 15:10 SUBCLAVIAN/AXILLARY ARTERY ANEURYSMS IN TWO RELATIVES – A NOVEL MUTATION IN FILAMIN A GENE – R. Perme
15:10 – 15:20 TOCILIZUMAB THERAPY IN REFRACTORY TAKAYASU ARTERITIS: REAL LIFE EXPERIENCE – V. Tsay
15:20 – 15:30 SURGICAL TREATMENT OF EXTRACRANIAL INTERNAL CAROTID ARTERY ANEURYSM – V. Pazur
15:30 – 15:40 PRELIMINARY RESULTS OF THE LIMBSAVE REGISTRY (TREATMENT OF CRITICAL LIMB ISCHEMIA WITH INFRAGENICULAR BYPASS ADOPTING IN SITU SAPHENOUS VEIN TECHNIQUE) – V. Sanna
15:40 – 15:50 IN-SITU NEEDLE FENESTRATION TECHNIQUE TO TREAT AORTIC ARCH PATHOLOGIES WITH HOSTILE LANDING ZONES – M. Luo
15:50 – 16:00 USEFULNESS OF PTFEE COVERED STENTS IN THE RESCUE OF FAILIONG ACCESSES FOR HEMOSALYSIS – F. J. Peinado Cebrián
15:30 – 17:00 Ischemic diabetic foot Hall 1
Chairs: D. Benevento & S. De Marchi
15:30 – 15:50 Diabetes, ischemia and inflammation – F. Mannello
15:50 – 16:10 Diagnostic approach – G. Failla
16:10 – 16:30 Chronic limb threatening ischemia – G. Clerici
16:30 – 16:45 Hot issues and unsolved tasks of diabetic foot care – Z. Pecsvarady
16:45 – 17:00 Post procedural functional recovery – E. Secolo
15:30 – 17:00 Controversies, up to date and what’s new in Latin American Phlebology Hall 2
Chairs: P. Komlos & J. Ulloa
15:30 – 15:45 Cryosclerotherapy and cryolaser in C1 patients – J. Ferreira
15:45 – 16:00 Venous mapping. What should we get consensus? – O. Bottini
16:00 – 16:15 Varicose veins with lymphedema. Whom to treat first. The challenge – H. J. Guedes
16:15 – 16:30 VTE after echoguided foam sclerotherapy – E. Toledo de Aguiar
16:30 – 16:45 Patient safety in phlebology treatment – A. Gariglio
16:45 – 17:00 Complications of foam sclerotherapy. How to avoid them? – S. Evangelista
16:00 – 17:00 Free Communications of IUA Youth Committee Hall 3
Chairs: R. Lainez Rube & N. Hamada
16:00 – 16:10 CHRONIC MESENTERIC ISCHEMIA RESULTING FROM ISOLATED LESIONS OF THE CELIAC TRUNK – R. Lainez Rube
16:10 – 16:20 THROMBIN-ANTITHROMBIN COMPLEX IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM AND PERIPHERAL ARTERIAL DISEASE UNDERGOING ENDOVASCULAR INTERVENTIONS – M. Juszynski
16:20 – 16:30 CLINICAL SIGNIFICANCE OF D-DIMER AND INTESTINAL FATTY ACID BINDING PROTEIN IN PATIENTS WITH ACUTE SUPERIOR MESENTERIC VEIN THROMBOSIS – J. Wan
16:30 – 16:40 ENDOVASCULAR SHARP RECANALIZATION FOR CALCIFIED FEMORAL ARTERY OCCLUSION – M. Islam
16:40 – 16:50 INFLUENCE OF RESTRICTED BLOOD FLOW EXERCISE WITH COOLING ON ENDOTHELIUM FUNCTION AND ANGIOGENESIS – M. Schönborn
16:50 – 17:00 SPONTANEOUS ULCERATION IN LOWER LIMB AFTER 40 YEARS OF BOTROPIC ACCIDENT – A. P. Nazario
17:00 – 17:30 Point on Hall 1
Chairs: G. Failla & F. Lurie
17:00 – 17:15 Patients with peripheral arterial disease: what benefits with the new ASA-rivaroxaban therapeutical approach? – O. Martinelli
17:15 – 17:30 From clinical evidence to guidelines; the rivaroxaban answers in VTE patients – A. Santoliquido

EUROPEAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY & CENTRAL EUROPEAN VASCULAR FORUM

17:30 – 19:00 Diagnosis and treatment of deep venous thrombosis Hall 1
Chairs: S. Novo & K. Roztocil
17:30 – 17:45 Role of endothelial dysfunction and inflammation in the pathogenesis of DVT – P. Poredos
17:45 – 18:00 Factors influencing recanalization of DVT and the development of post-thrombotic syndrome –

Z. Pecsvarady

18:00 – 18:15 Revised clinical classification of the Post-Thrombotic Syndrome (PTS) and the restricted role of medical

elastic stockings for symptomatic relief of PTS – J. J. Michiels

18:15 – 18:30 Advantages and disadvantages of DOAC in the treatment of venous thromboembolism – J. Pitha
18:30 – 18:45 Venous thromboembolism in oncology: Prevention and treatment – C. Amato
18:45 – 19:00 The endoluminal revolution in the management of venous disease – evidence and pitfalls –

J. Fernandes e Fernandes

INTERNATIONAL UNION OF ANGIOLOGY 

17:00 – 18:00 News from the world of phlebology Hall 2
Chairs: I. Bihari & K. Bozkurt
17:00 – 17:10 Laser crossectomy: 10 years of experience – I. Bihari
17:10 – 17:20 Cryostripping: 7 years of experience in the treatment of varicose veins – S. Oliaru
17:20 – 17:30 Reporting outcomes of EVLA of GSV – R. F. Vellettaz
17:30 – 17:45 Current role of the cyanoacrylate glue ablation for chronic venous insufficiency – K. Bozkurt
17:45 – 18:00 The treatment of pelvic venous disorders – J. L. Monedero
17:00 – 18:30 Free Communications of IUA Youth Committee Hall 3
Chairs: L. Gazzabin & S. Ray Pandey
17:00 – 17:10 CAROTID ENDARTERECTOMY AND AUTOLOGOUS VGS PATCHES: IMMEDIATE AND LONG-TERM RESULTS ANALYSIS OF SINGLE-CENTER CASES – A. Trani
17:10 – 17:20 IS A NEW COMBINED TREATMENT WITH LASER 980NM IN THE PROXIMAL GSV AND FOAM SCLEROTHERAPY AT THE DISTAL GSV IS USEFUL NOWADAYS TO TREAT THE VENOUS INCOMPETENCE OF THE LOWER EXTREMITIES? – R. Reachi Lugo
17:20 – 17:30 RECONSTRUCTIVE AND REGENERATIVE SURGERY IN DIABETIC FOOT TREATMENT – L. Gazzabin
17:30 – 17:40 FEATURES OF TREATMENT OF DEEP VEIN THROMBOSIS, COMPLICATED WITH PULMONARY EMBOLISM – Y. Khrebtiy
17:40 – 17:50 THE TREATMENT OPTIONS FOR RUPTURED ABDOMINAL AOTIC ANEURYSMS – Y. Zhao
17:50 – 18:00 CEREBROEMBOLIC OUTCOMES OF RIGHT VERSUS LEFT UPPER EXTREMITY ACCESS DURING FENESTRATED-BRANCHED ENDOVASCULAR AORTIC REPAIR – E. Tenorio
18:00 – 18:10 DEEP VEIN BYPASS IN COMPARISON TO VENOPLASTY/STENTING FOR ILIAC VEIN OCCLUSIVE DISEASE: AN INDIAN PERSPECTIVE – R. Nadumaskeri Subraya
18:10 – 18:20 COMPARISON OF EARLY AND LONG-TERM RESULTS OF OPEN REPAIR OF INFLAMMATORY ABDOMINAL AORTIC ANEURYSMS – P. Zlatanovic
18:00 – 19:00 Workshop on: Carotid and transcranial duplex ultrasound Hall 2
Chairs: L. Aluigi & O. Martinelli
18:30 – 19:30 Free Communications Hall 3
Chairs: L. R. Guo & J. Oliveira-Pinto
18:30 – 18:40 THE INITIAL APPLICATION OF PARAMETRIC COLOR-CODED DIGITAL SUBTRACTION ANGIOGRAPHY IN EVALUATION OF ACUTE LOWER LIMB ISCHEMIA AFTER ENDOVASCULAR TREATMENT – W. Li
18:40 – 18:50 RESULTS OF ENDOVASCULAR TREATMENT PATIENTS WITH ACUTE AND CHRONIC THORACIC AORTA DISSECTION – 19 YEARS OF SINGLE CENTER EXPERIENCE – M. Szostek
18:50 – 19:00 OUTCOMES OF UNILATERAL VERSUS BILATERAL USE OF GORE EXCLUDER ILIAC BRANCH ENDOPROSTHESIS FOR ELECTIVE ENDOVASCULAR TREATMENT OF AORTO-ILIAC ANEURYSMS – E. Tenorio
19:00 – 19:10 OUTCOMES OF FENESTRATED-BRANCHED ENDOVASCULAR AORTIC REPAIR IN PATIENTS WITH SOLITARY KIDNEY – E. Tenorio
19:10 – 19:20 EFFECT OF CELIAC AXIS COMPRESSION ON BRANCH-RELATED OUTCOMES DURING FENESTRATED-BRANCHED ENDOVASCULAR AORTIC REPAIR – F. Squizzato
19:20 – 19:30 INFLUENCE OF PERIOPERATIVE RISK FACTORS ON THE DEVELOPMENT OF TRANSMURAL COLONIC ISCHEMIA AFTER EMERGENT OPEN REPAIR OF RUPTURED ABDOMINAL AORTIC ANEURYSM – P. Zlatanovic

CHINA CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY

08:00 – 09:30 Vascular and endovascular treatment of arterial diseases: Experience from China Hall 1
Chairs: Y. Gu & P. Liu
08:00 – 08:15 Clinical outcomes of total endovascular treatment of type B aortic dissection with aberrant right subclavian artery – Z. Shi
08:15 – 08:30 Application of angiographosome concept in the endovascular treatment of critical diabetic ischemia – D. Ji
08:30 – 08:45 Redefining DCB in BTK treatment – 12 months outcomes of AcoArt II study – L. R. Guo
08:45 – 09:00 Spontaneous isolated dissection of the superior mesenteric artery: Management strategy based on new morphological classification – D. L. Li
09:00 – 09:15 Strategy for treating coexist carotid artery and coronary artery disease – Z. Ye
09:15 – 09:30 Development of endovascular therapy on symptomatic vertebral stenosis – Y. Gu

INTERNATIONAL UNION OF ANGIOLOGY

08:00 – 09:00 Rehabilitation in vascular disease Hall 2
Chairs: A. Caggiati & M. Klonizakis
08:00 – 08:20 The IUP Consensus on rehabilitation of venous disease – A. Caggiati
08:20 – 08:40 Therapeutic education combined with balneotherapy in lymphedema patients – P. Carpentier
08:40 – 09:00 Understanding the role of microcirculation: Microcirculatory effects of physical therapies – M. Klonizakis

INTERNATIONAL UNION OF ANGIOLOGY & ITALIAN SOCIETY FOR VASCULAR MEDICINE

08:00 – 09:30 Good clinical practice in lower extremity artery disease (LEAD) Hall 3
Chairs: E. Arosio & P. Tondi
08:00 – 08:15 Epidemiology of LEAD in Europe – L. Mazzolai
08:15 – 08:30 Diagnostic tool in detection of preclinical and clinical lower extremity artery disease – P. Poredos 
08:30 – 08:45 Role of biomarkers in lower extremity artery disease pathogenesis: New insights – F. Mannello
08:45 – 09:00 Clinical practice in lower extremity artery disease – A. Mansilha
09:00 – 09:15 Management of asymptomatic LEAD and symptomatic patients with II stage LEAD – L. Aluigi
09:15 – 09:30 Clinical approach for physical training and reduction of cardiovascular risk in LEAD – S. De Marchi
09:00 – 11:00 Keynote Lectures Hall 2
Chairs: L. R. Guo & S. Novo
09:00 – 09:30 Outpatient management of acute pulmonary embolism – R. Shields
09:30 – 10:00 MPFF in Italy, partner of HCPs and patients for chronic venous disease management – P. L. Antignani
10:00 – 10:30 Training path for phlebologists in Europe – D. Radu
10:30 – 11:00 Basic research on cardiovascular models – R. Scalia

INTERNATIONAL UNION OF ANGIOLOGY

09:30 – 11:00 Unmet needs in venous disease Hall 1
Chairs: J. Fareed & A. Nicolaides
09:30 – 09:45 Best practice and unmet needs in chronic venous disease management – A. Mansilha
09:45 – 10:00 New insights in varicose veins medical management – J. Raffetto
10:00 – 10:15 Focus on patients with skin alteration (C4-C6) – T. Urbanek
10:15 – 10:30 Best practice and unmet needs in venous thromboembolism management – A. Nicolaides
10:30 – 10:45 Management of unsuitable patients for OACs therapy – G. Palareti
10:45 – 11:00 High risk patients for CVU development after DVT episode – L. Chernukha
11:00 Final remarks – J. Fareed

INTERNATIONAL UNION OF ANGIOLOGY & SLOVENIAN SOCIETY FOR VASCULAR DISEASE

09:30 – 11:00 Advances in the treatment of vascular diseases Hall 3
Chairs: L. Belova & M. Kozak
09:30 – 09:45 Home treatment of pulmonary embolism – our experiences – T. Vižintin Cuderman
09:45 – 10:00  Venous thromboembolism prophylaxis in the hospital – cross–sectional study M. Kozak
10:00 – 10:15 Safety of outpatient treatment with oral anticoagulation drugs – Ljubljana registry – T. Vižintin Cuderman
10:15 – 10:30 Cerebral venous thrombosis L. Belova
10:30 – 10:45 Incidental vs. symptomatic abdominal venous thromboses during anticoagulation: Data from the RIETE registry – P. Di Micco
10:45 – 11:00 Thromboembolic disorders and pregnancy – H. Kiesewetter

SPONSORED SESSION

11:00 – 12:30 Chronic venous disease (CVD) and diabetes: Looking beyond the veins Hall 1
Chairs: K. Zorriasateyn & A. Mansilha
11:00 – 11:15  CVD: Pathophysiology, risk factors and comorbidities – A. Mansilha
11:15 – 11:30 The puzzle of diabetic complications and related risk factors – G. Gastaldi
11:30 – 11:45  Unraveling the differences and similarities between CVD and DM – K. Bozcurt
11:45 – 12:00 Treating microvascular complications in the kidney – J. Menne
12:00 – 12:15 Microvascular complications in the eye – R. Simò
12:15 – 12:30 Discussion
12:30 – 13:00 Keynote Lecture Hall 1
Chair: P. L. Antignani
12:30 – 13:00 Development of surgical treatment of lower limb ischemia in China – Y. Gu
13:00 – 14:00 BREAK
14:00 – 15:00 Connective tissue vascular diseases Hall 1
Chairs: P. L. Antignani & P. Carpentier
14:00 – 14:20 Capillaroscopy in scleroderma – J. Constans
14:20 – 14:40 Digital arterial pressure measurements – S. Blaise
14:40 – 15:00 Rehabilitation in patients with scleroderma – M. Klonizakis

AUSTRIAN SOCIETY OF PHLEBOLOGY AND ANGIOLOGY, DERMATOLOGY & AUSTRIAN SOCIETY OF INTERNAL MEDICINE AND ANGIOLOGY & ITALIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHLEBOLOGY

14:00 – 15:30 Management of venous thromboembolism Hall 2
Chairs: C. Allegra & P. Marschang
14:00 – 14:15 Venous thromboembolism prophylaxis – P. Zamboni
14:15 – 14:30 Endovascular treatment of pulmonary embolism – P. Marschang
14:30 – 14:45 Endovascular treatment for proximal early thrombus removal – M. Danese
14:45 – 15:00 Endovascular treatment of deep venous thrombosis – O. Schlager
15:00 – 15:15 Chronic outflow obstruction: Recanalization techniques in complex cases – C. Ambrogi
15:15 – 15:30 Endovascular treatment of the post thrombotic syndrome – F. Hafner

INTERNATIONAL UNION OF ANGIOLOGY &  ASSOCIATION OF VASCULAR SURGEONS, PHLEBOLOGISTS, ANGIOLOGISTS OF UKRAINE

14:00 – 16:00 Controversies in vascular diseases Hall 3
Chairs: L. Chernukha & A. Mansilha
14:00 – 14:15 PAD and medical treatment: What’s new in guidelines? – P. Poredos
14:15 – 14:30 Catheter directed thrombolytic treatment of peripheral arterial occlusions – M. Kozak
14:30 – 14:45 Enhancing of hypoxic cells defense system in patients with intermittent claudication in course of training – S. De Marchi
14:45 – 15:00 Association of provisional stenting with long-term all-cause mortality for femoropopliteal artery disease-a further analysis of 5-year outcome of the ACOART I study – J. Liu
15:00 – 15:15 Pathogenetic approaches in the treatment of congenital vascular limb malformation – L. Chernukha
15:15 – 15:30 Redo peripheral endovascular interventions – tunisian experience – T. Sraieb
15:30 – 15:45 Features of the diagnosis of pelvic congestion syndrome – M. Orel
15:45 – 16:00 Discussion aspects concerning the use of laser ablation in patients with varicose veins – I. Gudz 

INTERNATIONAL UNION OF ANGIOLOGY

15:00 – 16:30 Cerebro vascular diseases Hall 1
Chairs: G. Oderich & J. Pitha
15:00 – 15:15 New carotid diseases guidelines – A. L. Abbott
15:15 – 15:30 Carotid endarterectomy and stenting- comparison of two methods performed in the same patient – P. Myrcha
15:30 – 15:45 Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythaemia associated with jak2 v617f – A. Blinc
15:45 – 16:00 Optimal timing of carotid interventions in symptomatic patients – P. Gloviczki
16:00 – 16:15 Carotid body tumor – preoperative embolization in individualized treatment – T. Cohnert
16:15 – 16:30 Urgent carotid endarterectomy: The referral center experience – M. Markovic

INTERNATIONAL UNION OF ANGIOLOGY

15:30 – 16:15 Will the new CEAP change the clinical practice Hall 2
Chairs: P. Carpentier & P. L. Antignani
15:30 – 15:45 Historical introduction – B. Eklof
15:45 – 16:00 The main improvements in the 2020 CEAP version – F. Lurie
16:00 – 16:15 What the new CEAP will change in clinical practice. The physician point of view – P. Carpentier

INTERNATIONAL UNION OF ANGIOLOGY

16:00 – 17:30 Updates in the management of chronic venous and lymphatic disease Hall 3
Chairs: D. Kontothanassis & A. Mansilha
16:00 – 16:15 Mathematical modelling of the venous wall dilatation – E. Goranova
16:15 – 16:30 At 20 years of coumarin bandage for venous ulcers – F. Vega Resgado
16:30 – 16:45 Endovascular treatment of varicose veins: What is better? – I. Bihari
16:45 – 17:00 Photo-termography approach to assessment of venous leg ulcer – A. Jawien
17:00 – 17:15 Consensus and evidence-based guidelines for management of chronic lymphedema – M. Gloviczki
17:15 – 17:30 Microfoam sclerotherapy in recurrent varicose veins following surgery – E. Intriago
16:15 – 17:15 Free Communications Hall 2
Chairs: M. K. Jezovnik & D. Benevento
16:15 – 16:22 THE EFFECT OF SUPERVISED STANDING, LYING AND COMPRESSION ON THROMBIN GENERATION IN REGIONAL VENOUS BLOOD – C. Lattimer
16:22 – 16:29 EPIDEMIOLOGICAL ASPECTS OF COMBINATION OF LOWER LIMBS CHRONIC VENOUS DISEASE (CVD) AND PELVIC CONGESTION SYNDROME (PCS): THE PRELIMINARY RESULTS OF UKRAINIAN STUDY “DETECT 1000” – G. Vlaikov
16:29 – 16:36 CILOSTAZOL AS A NON-INFERIORITY PHARMACOLOGICAL OPTION TO PACLITAXEL IN INTIMAL HYPERPLASIA INHIBITION AFTER VENOUS BALLOON ANGIOPLASTY IN A RABBIT MODEL – R. Lozano-Corona
16:36 – 16:43 SHORT TERM OUTCOME OF BARE METAL STENT VS COVERED STENT IN TREATMENT OF SYMPTOMATIC CENTRAL VENOUS OCCLUSION IN ASSOCIATION WITH FUNCTIONING UPPER LIMB ARTERIO-VENOUS ACCESS – A. Mohammed
16:43 – 16:50 EXPERIENCE OF INTRAVASCULAR ULTRASOUND (IVUS) GUIDED ILIAC VEIN STENTING FOR MAY-THURNER’S SYNDROME – H. Ohe
16:50 – 16:57 CLINICAL CHARACTERISTICS AND TREATMENT OF FEMORAL PSEUDOANEURYSMS SECONDARY TO INTRAVENOUS DRUG ABUSE IN CHINA: A SINGLE CENTER STUDY – Z. Wu
16:57 – 17:04 A CASE OF LIVER ABSCESS WITH METASTATIC SEPTIC ENDOPHTALMITIS AND HEPATIC VEIN THROMBOSIS – P. Brugnaro
17:04 – 17:11 TWO-YEAR OUTCOMES OF PACLITAXEL-COATED BALLOONS FOR FEMOROPOPLITEAL ARTERY DISEASE WITH CALCIUM LESION – J. Liu

INTERNATIONAL UNION OF ANGIOLOGY 

16:30 – 17:30 Progress and perspectives in phlebology Hall 1
Chairs: G. B. Agus & E. Intriago
16:30 – 16:45 A new approach to the management of the post-thrombotic syndrome – T. Urbanek
16:45 – 17:00 A pragmatic approach of varicose veins of the lower limbs of pelvic origin – T. Wassila
17:00 – 17:10 When and which protocol should be used to prevent DVT after endovenous ablation in high thrombotic risk patients? – S. Olariu
17:10 – 17:20 Catheter directed thrombolysis for acute iliofemoral DVT – Predictors of outcome – E. Hussein
17:20 – 17:30 Vena cava filter deployment prior to percutaneous endovenous therapy for proximal lower limb deep venous thrombosis: should we routinely practice? – M. Ismail
17:15 – 18:15 Free Communications Hall 2
Chairs: G. Failla & J. Markovic
17:15 – 17:22 THE ROLE OF ADJUNCTIVE INTERMITTENT PNEUMATIC COMPRESSION IN PATIENTS AT EXTREMELY HIGH RISK OF POSTOPERATIVE VENOUS THROMBOEMBOLISM – K. Lobastov
17:22 – 17:29 TELEANGECTASIA TREATMENT BY MEANS OF AN INNOVATIVE COMBINATION OF 532 AND 940 NM TRANSDERMAL DIODE LASER – S. Gianesini
17:29 – 17:36 THE CLACS CERTIFICATION: DIFFICULTIES TO IMPLEMENT IN RUSSIA – E. Berezhnoi
17:36 – 17:43 ALTERNATIVE ANESTHESIA FOR LESS-INVASIVE PERIPHERAL ARTERY BYPASS – O. Sogabe
17:43 – 17:50 WHICH PATIENTS ARE AT HIGH RISK FOR ELEVATED UC – MGP LEVEL LEADING TO ARTERIAL CALCIFICATION AND SEVERE CARDIO – VASCULAR DISEASE? – R. Kreidy
17:50 – 17:57 INFRARENAL AORTIC DIAMETER IS ASSOCIATED WITH HYPERTENSIVE RETINOPATHY IN CHINESE HYPERTENSIVE ADULTS – J. Liu
17:57 – 18:04 OUTCOMES OF CRYOPRESERVED ALLOGRAFTS FOR AORTIC INFECTIONS – M. Khasawneh
18:04 – 18:11 OUTCOMES OF OPEN SURGERY AND ENDOVASCULAR REPAIR FOR MYCOTIC AORTIC ANEURYSMS: THE POTENTIAL BENEFITS BEYOND SURVIVAL RATES – M. Liu
17:30 – 18:15 Digital health Hall 1
Chairs: T. Karplus & K. Roztocil
17:30 – 17:45 Digital angiology – S. Pillon
17:45 – 18:00 Digital plebology – A.Orsini
18:00 – 18:15 Digital health infrastructure – G. Viglialoro
17:30 – 18:30 Free Communications Hall 3
Chairs: V. Brusegan & F. Passariello
17:30 – 17:37 THE IMPACT OF DISTAL TEARS AFTER PROXIMAL REPAIR OF STANFORD TYPE B AORTIC DISSECTION – S. Zhang
17:37 – 17:44 VALUE OF 3D PRINTING IN COMPLEX AORTIC SURGERY – L. F. Rinaldi
17:44 – 17:51 MAIN RENAL ARTERY COVERAGE DURING ENDOVASCULAR JUXTARENAL AORTIC ANEURYSM REPAIR: A CASE REPORT AND LITERATURE REVIEW – R. Shields
17:51 – 17:58 HYPERHOMOCYSTEINEMIA IS AN INDEPENDENT RISK FACTOR OF THORACOABDOMINAL AORTIC ANEURYSM IN A CHINESE HAN POPULATION – J. Liu
17:58 – 18:05 ROBOTIC TREATMENT OF SPLENIC ARTERY ANEURYSMS: TECHNICAL INSIGHTS AND FUTURE PERSPECTIVES – L. F. Rinaldi
18:05 – 18:12 SURGICAL SCLEROMOUSSE OF THE SAPHENOUS VEINS – G. A. Murgiano
18:12 – 18:19 OUTCOMES OF STANDARD VERSUS LOW-PROFILE FENESTRATED-BRANCHED ENDOVASCULAR AORTIC REPAIR FOR PARARENAL AND THORACOABDOMINAL ANEURYSMS – E. Tenorio
18:19 – 18:26 FLOATING STRUCTURE IN THE CAROTID ARTERY AND STROKE. IS ENDOVASCULAR INTERVENTION REQUIRED? – L. Di Pino

INTERNATIONAL UNION OF ANGIOLOGY

18:15 – 19:00 Pathophysiology, biochemistry and therapy of chronic venous disease: The state-of-the-art Hall 1
Chairs: F. Mannello & J. Raffetto
18:15 – 18:30 Pathophysiology of chronic venous disease – F. Mannello
18:30 – 18:45 Implications of treatment for chronic venous disease – J. Raffetto
18:45 – 19:00 Research progress and future directions for chronic venous disease – S. Onida
18:15 – 19:15 Free Communications Hall 2
Chairs: A. Izzo & Z. Lazarashvili
18:15 – 18:22 A RANDOMIZED TRIAL OF MODERATE (CLASS 2), HIGH (CLASS 3) AND VERY HIGH (CLASS 4) ELASTIC COMPRESSION IN THE PREVENTION OF RECURRENCE OF VENOUS ULCERATION – D. Milic
18:22 – 18:29 JOURNEY FROM OPEN TO ENDOVENOUS SURGERY: EXPERIENCE OF 100 CASES AS A BEGINNER – S. K. Ghosh
18:29 – 18:36 GROWTH HORMONE THERAPY DECREASES INFLAMMATION AND IS BENEFICIAL FOR WOUND HEALING AND REST PAIN RELIEF IN CHRONIC LIMB THREATENING ISCHEMIA – D. Caicedo Valdés
18:36 – 18:43 ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH SECONDARY LYMPHEDEMA OF THE LOWER EXTREMITIES AS A CRITERION OF THE EFFECTIVENESS OF PHARMACOTHERAPY – I. Suchkov
18:43 – 18:50 VARICOSE VEIN RECURRENCY SCORE SYSTEM FOR LASER SURGERY – I. Bihari
18:50 – 18:57 ARTERIAL AND VENOUS INVASION OF THREE PERIODONTAL BACTERIA IN A RAT MODEL SHOWS BUERGER’S DISEASE-LIKE PATHOLOGY AND WHAT IS THE NEXT – T. Iwai
18:57 – 19:04 URINARY LEUKOTRIENE E4 – THE NEW HOPE FOR SUCCESSFUL PREDICTION OF RECURRING RESTENOSIS IN PATIENTS UNDERGOING ENDOVASCULAR TREATMENT – M. Maga

7

INTERNATIONAL UNION OF ANGIOLOGY & CZECH SOCIETY OF ANGIOLOGY

08:00 – 09:00 Treatment of various aortic diseases: Is it still a challenge? Hall 1
Chairs: D. Karetova & K. Roztocil
08:00 – 08:20 Management of complex type A aortic dissection with open surgery and endovascular techniques, results of single centre study – P. Vařejka
08:20 – 08:40 Large vessel vasculitis in the 21st century – new promising drugs – A. Jenisova
08:40 – 09:00 Long term follow-up of patients after EVAR – endoleak management – J. Pudil

INTERNATIONAL UNION OF ANGIOLOGY

08:00 – 09:30 Update in venous diseases from the world Hall 3
Chairs: A. Bradbury & A. Scuderi
08:00 – 08:15 Ultrasound guide foam sclerotherapy: Latino american guidelines – S. Garbarz
08:15 – 08:30 The classic and distal crossectomy as alternatives against endovascular surgery – F. Vega Resgado
08:30 – 08:45 The point of endovascular treatments – D. Kontothanassis
08:45 – 09:00 Ultrasound guided foam sclerosis: Is it a surgical alternative in the elderly? – E. Intriago
09:00 – 09:15 Treatment of post thrombotic disease: Does the compression level influence the outcome? – E. Ivanov
09:15 – 09:30 Microfoam sclerotherapy in recurrent varicose veins following surgery – S. Evangelista
09:00 – 10:30 New strategies for preventing pulmonary embolism, DVT and stroke Hall 1
Chairs: J. Saucedo & J. Walenga
09:00 – 09:15 Clinical unmet needs in DVT prevention. A focus on medically ill patients – E. Ramacciotti
09:15 – 09:30 VTE risk assessment paradigms in medical and surgical patients – A. Tafur
09:30 – 09:45 Provoked versus unprovoked VTE. Is it time to revisit the terms? – E. Ramacciotti
09:45 – 10:00 VTE prevention in cancer patients – what is new? – A. Tafur
10:00 – 10:10 Recent advances in the management of ischemic stroke. A focus on anticoagulants – K. Zorriasateyn
10:10 – 10:20 Rapid response approaches for the management of VTE. A team effort – J. Saucedo
10:20 – 10:30 Newer approaches including factor XIa inhibitors for the management of  VTE – W. Jeske

INTERNATIONAL UNION OF ANGIOLOGY & INTERNATIONAL UNION OF PHLEBOLOGY

09:30 – 11:00 The international point on venous diseases Hall 2
Chairs: A. Bradbury & P. L. Antignani
09:30 – 09:45 SFALT – a new LASER-foam treatment for saphenous varices – L. Tessari
09:45 -10:00 Similarities and controversies in international phlebo-lymphology guidelines – S. Gianesini
10:00 -10:15 Deep venous stenting in post thrombotic syndrome – S. Doganci
10:15 – 10:30 Pelvic congestion syndrome: The UIP consensus – Z. Lazarashvili
10:30 – 10:45 The point on thermal ablation of varicose veins – M. Vuylsteke
10:45 – 11:00 A critical appraisal of venous research – C. Wittens

CENTRAL EUROPEAN VASCULAR FORUM & ITALIAN COUNCIL FOR CARDIOVASCULAR RISK REDUCTION

09:30 – 11:00 Arterial hypertension as a risk factor of vascular diseases Hall 3
Chairs: : E. Agabati Rosei & V. Stvrtinova
09:30 – 09:50 Can hypertensive vascular damage be reversible? – E. Agabiti Rosei
09:50 – 10:10 Arterial hypertension as a risk factor for atherosclerotic peripheral arterial disease of lower limbs – D. Celovska
10:10 – 10:30 Arterial hypertension as a risk factor for chronic venous disease – V. Stvrtinova
10:30 – 10:45 Risk factors for atherosclerosis in Slovak secondary school students – K. Dostalova
10:45 – 11:00 Adherence to antihypertensive treatment in real life medicine – E. Agabiti Rosei
10:30 – 11:00 IUA chapter vice president reports Hall 1
Chairs: Y. Gu & T. Karplus
P. L. Antignani (Europe) – J. Fareed (North America) – P. Komlos (Latina America) – P. Liu (China) –

P. Poredos (Multinational Chapter)

11:00 – 13:00 Keynote Lectures Hall 1
Chairs: Y. Gu & P. L. Antignani
11:00 – 11:30 Harm reduction in the context of cardiovascular diseases – R. Zimlichman
11:30 – 11:50 Appropriate use of innovations and update of guidelines for management of chronic venous disease – P. Gloviczki
11:50 – 12:10 The state of the art of aortic arch repair – G. Oderich
12:10 – 12:30 Microvascular decompensation: The common pathway of severe arterial and venous diseases – P. Carpentier
12:30 – 13:00 Phlebolympoedema – B. B. Lee
13:00 – 14:00 BREAK

ASIAN SOCIETY FOR VASCULAR BIOLOGY

14:00 – 15:00 The regulation of vascular homeostasis and the roles of perivascular adipose tissue Hall 1
Chairs: H. Shimokawa & Y. Wang
14:00 – 14:20 Shear stress and endothelial cell function – Y. Huang
14:20 – 14:40 Perivascular adipose tissue and the regulation of Kv7 channels: Implications for resistant hypertension – M. Gollasch
14:40 – 15:00 Anti-contractile activity of SIRT1 in perivascular adipose tissue – Y. Wang

MULTINATIONAL CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY

14:00 – 15:30 How to manage patients with multifocal atherosclerotic disease (MFAD)? Hall 2
Chairs: S. Novo & P. Poredos
14:00 – 14:15 The interrelationship between different atherosclerotic diseases – S. Novo
14:15 – 14:30 PAD as an indicator of systemic atherosclerosis – P. Poredos
14:30 – 14:45 Diagnostic approach to the patient with a suspected MFAD – A. Blinc
14:45 – 15:00 Do patients with MFAD need more aggressive preventive and therapeutic measures – M. K. Jezovnik
15:00 – 15:15 Priorities of revascularization procedures in patients with MFAD – J. Fernandes y Fernandes
15:15 – 15:30 Atherosclerosis and immune system – M. Taurino

INTERNATIONAL UNION OF ANGIOLOGY & POLISH SOCIETY FOR ANGIOLOGY – POLISH SOCIETY OF PHLEBOLOGY

14:00 – 15:30 News in vascular medicine Hall 3
Chairs: P. Terlecki & T. Urbanek
14:00 – 14:15 Physical medicine in angiology – A. Sieroń
14:15 – 14:30 Lymphatic function in chronic venous disease – A. Szuba
14:30 – 14:45 Three-years follow-up of the use of Flebogrif system in the treatment of varicose veins of lower extremities – T. Zubilewicz
14:45 – 15:00 Iliac vein stenting in chronic venous disease – A. Rajeev
15:00 – 15:15 Reducing hyperpigmentation after sclerotherapy (RHyAS) study: Results of a multicentre, randomized, controlled, clinical trial – A. G. Ochoa
15:15 – 15:30 How to deal with the complications of phlebological procedures? – T. Urbanek

INTERNATIONAL UNION OF ANGIOLOGY

15:00 – 16:00 Aortic arch repair Hall 1
Chairs: P. Gloviczki & Y. Gu
15:00 – 15:20 How to manage aortic arch pathology: open, hybrid, chimney or fenestration – C. Shu  
15:20 – 15:40 Risk of stroke in patients with left subclavian artery overstented during endovascular treatment of thoracic aorta diseases – M. Szostek  
15:40 – 16:00 Selective extracorporeal circulation combined with in situ needling fenestration in endovascular repair of aortic arch lesions – L. Wei  
15:30 – 16:30 Free Communications Hall 2
Chairs: A. Jawien & L. R. Guo
15:30 – 15:40 CLINICAL IMPORTANCE OF PERIPHERAL ULTRASOUND DIAGNOSTIC IN PATIENTS WITH HIGH GRADE AORTIC STENOSIS SHEDULED FOR ELECTIVE AORTIC VALVE REPLACEMENT – D. Bojadgieva-Marincheva
15:40 – 15:50 CHARACTERISATION OF ISCHEMIA AND HAEMORRHAGE MOUSE STROKE MODELS FOR EFFICIENT DRUG DEVELOPMENT – H. Nandurkar
15:50 – 16:00 NATIONAL TRENDS OF SPONTANEOUS CORONARY ARTERY DISSECTION: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE – A. Mata
16:00 – 16:10 IS PLASMA HOMOCYSTEIN A RISK MARKER FOR CAROTID ARTERY DISEASE IN PATIENTS WITH CORONARY ARTERY DISEASE – M. Bosevski
16:10 – 16:20 EFFICACY OF INVOS CEREBRAL OXIMETER IN DETECTING NEUROLOGIC COMPLICATIONS IN CAROTID ENDARTERECTOMY – F. Jàcome
16:20 – 16:30 THE PROGNOSTIC VALUE OF SIMPLE FRAILTY AND MALNUTRITION TOOLS IN DETERMINING SURGICAL RISK IN PATIENTS WITH CHRONIC CRITICAL LEG ISCHAEMIA – J. Palmer
15:30 – 16:30 Keynote Lectures Hall 3
 Chair: J. Fareed & J. Walenga
15:30 – 16:00 Kakkar Lecture: Changing paradigms in the management of VTE. Progress in the last two decades and projections for the next two decades – E. Ramacciotti
16:00 – 16:30 Breddin Lecture: Is there a connection between diabetes and venous diseases? – K. Roztocil
16:00 – 17:00 Free Communications Hall 1
Chairs: B. Fazeli & J. Markovic
16:00 – 16:07 TREATMENT OF HIGH-RISK PREGNANCIES WITH TINZAPARIN – H. Kiesewetter
16:07 – 16:14 ACUTE ARTERIAL THROMBOSIS SECONDARY TO COMBINED INHERITED AND ACQUIRED THROMBOPHILIA – R. Kreidy
16:14 – 16:21 EVALUATION OF GLOBAL COAGULATION ASSAYS IN PATIENTS WITH CHRONIC KIDNEY DISEASE – H. Y. Lim
16:21 – 16:28 MONOCYTE SUBSETS, INFECTIOUS AGENTS AND ATHEROSCLEROSIS – F. Del Porto
16:28 – 16:35 GLOBAL COAGULATION ASSAYS IN NORMAL CONTROLS: ARE THERE COMPENSATORY MECHANISMS WITHIN VIRCHOW’S TRIAD? – H. Y. Lim
16:35 – 16:42 ASSESSING THE IMPACT OF SWITCHING TO THE TOBACCO HEATING SYSTEM ON CARDIOVASCULAR DISEASE: TRANSLATING BASIC SCIENCE INTO CLINICAL BENEFIT – C. Pater
16:42 – 16:49 RELATIONSHIP BETWEEN ANGIOPOIETIN-2 ELEVATION AND ATRIAL FIBRILLATION REMAINS SIGNIFICANT FOLLOWING 1-YEAR TIME INTERVAL – J. Bontekoe
16:49 – 16:56 NO ASSOCIATION BETWEEN HOMOCYSTEINE LEVEL AND ISOLATED SUPERIOR MESENTERIC ARTERY DISSECTION – J. Liu
16:30 – 18:00 Free Communications Hall 2
Chairs: V. Canata & F. Tomaselli
16:30 – 16:40 ENDOVENOUS WELDING AS A MODERN AND EFFECTIVE TECHNIQUE FOR MINIMALLY INVASIVE TREATMENT OF LARGE DIAMETER VARICOSE VEINS – M. Chekhlov
16:40 – 16:50 COMPARISON EARLY WITH DEFERRED ENDOVENOUS LASER ABLATION FOR ACTIVE VENOUS LEG ULCER – O. Voloshyn
16:50 – 17:00 FOAM SCLEROTHERAPY AFTER VENOUS ABLATION OF THE SAPHENOUS VEIN TO REDUCE RECANALIZATION RATES AFTER 5 YEARS – I. Leon
17:00 – 17:10 FATE OF GROIN AFTER RADIOFREQUENCY ABLATION OF VARICOSE VEIN – E. Elashaal
17:10 – 17:20 SERIAL EMBOLIZATION OF A DISTAL MALFORMATION IN LEFT FOOT, THE IMPORTANCE OF CINICAL EVALUATION AND A CAREFUL PROCEDURE – N. Lecuona
17:20 – 17:30 SULODEXIDE AS ADJUVANT TO ANTICOAGULANT TREATMENT ON PATIENTS WITH LOWER EXTREMITY DEEP VEIN THROMBOSIS – L. Erasto
17:30 – 17:40 PREVENTION OF RECURRENT TROPHIC ULCERS IN PATIENTS WITH POSTTHROMBOTIC SYNDROME – O. Shymechko
17:40 – 17:50 INITIAL EXPERIENCE IN MECHANOCHEMICAL ABLATION (CLARIVEIN) – F. Aghayev
17:50 – 18:00 THE PREVALENCE AND TYPES OF CANCER AND ITS IMPACT IN THE PATIENTS WITH SUPERFICIAL VEIN THROMBOSIS – J. Hirmerová

CUBAN SOCIETY OF ANGIOLOGY AND VASCULAR SURGERY & NATIONAL INSTITUTE OF ANGIOLOGY AND VASCULAR SURGERY

16:30 – 17:30 Reducing high level amputations in diabetic foot ulcers: From the surgery to the application of intralesional epidermal growth factors Hall 3
Chairs: A. Garcia Herrera & T. Karplus
16:30 – 16:45 From the bench to the laboratory – J. Berlanga
16:45 – 17:00 Minimal local surgical procedures in diabetic foot ulcers – A. Fabelo
17:00 – 17:15 Intralesional application of epidermal growth factor in diabetic foot ulcers: Our results and experience – A. Garcia Herrera
17:15 – 17:30 Combining revascularization of the extremity and application of intralesional EGFrh, reduce costs and amputations in ischemic diabetic ulcers – C. Valdes Perez
17:00 – 17:30 Free communications Hall 1
Chairs: I. Cvjetko & A. Sampaio
17:00 – 17:07 SYMPTOMATIC CAROTID STENOSIS: LESSONS LEARNED AFTER 10 YEARS OF EXPERIENCE IN A HIGH-VOLUME CENTER – E. Lazzeri
17:07 – 17:14 ULTRASOUND-GUIDED SCLEROTHERAPY ON LARGES GREAT SAPHENOUS VEINS WITH 1% VS 2% VS 3% POLIDOCANOL FOAM: A RANDOMISED TRIAL – C. Amorim
17:14 – 17:21 VEINSCOPE- CHRONIC VENOUS DISEASE DETECTION DISEASE SYMPTOM SCREENING PROGRAM AT PRIMARY HEALTHCARE LEVEL – T. Mukhuradze
17:21 – 17:28 TRANSPOSITION OF SUBCLAVIAN ARTERY – IS IT THE APPROPRIATE CHOICE IN SUBCLAVIAN STEAL SYNDROME TREATMENT? – T. Ostrowski

VAS-EUROPEAN INDEPENDENT FOUNDATION IN ANGIOLOGY/VASCULAR MEDICINE

17:30 – 19:00 Milestones in Buerger’s disease Hall 3
Chairs: P. L. Antignani & B. Fazeli
17:30 – 17:45 Thromboangiitis obliterans from Leo Buerger point of view – B. Fazeli
17:45 – 18:00 Rise and fall in incidence of Buerger’s disease: Is it really because of incidence of tobacco consumption? – A. Szuba
18:00 – 18:15 Is tobacco an etiologic factor in Buerger’s disease or an aggravating factor? – T. Iwai
18:15 – 18:30 Challenges in diagnosis of Buerger’s disease? – E. Hussein
18:30 – 18:45 Buerger’s disease treatment: Invasive or conservative – M. Bashar
18:45 – 19:00 The next step for understanding Buerger’s disease: Introduction of VAS biobank on Buerger’s disease, as an association of BBMRI- M. Catalano
18:00 – 19:00 Free communications Hall 2
Chairs: S. Ray Pandey & Q. S. Lu
18:00 – 18:10 BELOW-THE-KNEE BLOOD FLOW DYNAMICS AS NOVEL PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS UNDERGOING ENDOVASCULAR TREATMENT – M. Maga
18:10 – 18:20 ELEVATED NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS MORTALITY FOLLOWING PERCUTANEOUS FEMORO-POPLITEAL INTERVENTIONS – J. Cho
18:20 – 18:30 EFFICIENT SCREENING OF THE DIABETIC MICROANGIOPATHY IN THE EVERYDAY PRACTICE – J. Matuška
18:30 – 18:40 SPECIFIC SLOW TESTS ARE NOT MANDATORY IN PATIENTS WITH EXTREMELY SHORT STANDARD (3.2KM/H 10% SLOPE) TESTS DURATIONS DURING EXERCISE OXIMETRY – P. Abraham
18:40 – 18:50 MEAN PLATELET VOLUME (MPV) AS A PREDICTOR OF VENOUS THROMBOEMBOLISM (VTE) IN COLORECTAL CANCER – C. Wilasrusmee
18:50 – 19:00 CHARACTERISTICS OF PULMONARY EMBOLISM WITH EARLY FATALITY – V. Macrinici
19:00 – 19:30 IUA general assembly Hall 1

INTERNATIONAL UNION OF ANGIOLOGY

08:00 – 09:30 Aneurysm of thoraco-abdominal aorta Hall 1
Chairs: P. Gloviczki & G. Oderich
08:00 – 08:15 Fenestrated branched repair of TAAAs – G. Oderich
08:15 – 08:30 AAA within aortic dissections – I. Cvjetko
08:30 – 08:45 Complications after endovascular repair of abdominal aortic aneurysm – O. Martinelli
08:45 – 09:00 Endovascular repair of abdominal aortic aneurysm with complex anatomy – C. Shu
09:00 – 09:15 Thoracoabdominal aneurysm treated with branched stent graft – A. Jawien
09:15 – 09:30 Current guidelines for elective repair of abdominal aortic aneurysms – P. Gloviczki

ITALIAN SOCIETY OF ANGIOLOGY AND VASCULAR MEDICINE & VAS-EUROPEAN INDEPENDENT FOUNDATION IN ANGIOLOGY/VASCULAR MEDICINE

08:00 – 09:30 Peripheral artery disease, the 21st epidemic: Between greater awareness and new therapeutic scenarios. Concrete aims and results Hall 2
Chairs: G. Arpaia & M. Catalano
08:00 – 08:15 PAD and cardio-vascular disease: Weight and chances – D. Olinic
08:15 – 08:30 Awareness: A call to action – G. Lessiani
08:30 – 08:45 International PAD strategic network – M. Catalano
08:45 – 09:00 The importance of administrative and registry data on PAD across Europe – M. Catalano
09:00 – 09:15 Horizon scanning within new therapeutic scenarios and innovative organization schemes – A. Visonà
09:15 – 09:30 Surgical approach and indications: The patients and the multidisciplinary vascular team – W. Dorigo

ITALIAN SOCIETY OF AESTHETIC MEDICINE & PAN-AMERICAN SOCIETY OF PHLEBOLOGY, LYMPHOLOGY AND AESTHETIC MEDICINE

09:30 – 11:30 News in phlebo-lymphology Hall 1
Chairs: A. Martinez Granados & F. Tomaselli
09:30 – 09:45 The volumes of lower limbs – S. Michelini
09:45 – 10:00 Vascular dyschromia and cutaneous eczema – T. Lotti
10:00 – 10:15 Bandaging in acute lymphangitis: Can/must we do it? – A. Macciò
10:15 – 10:30 Venous ulcer treatment with inelastic short stretch system – J. A. Serralde Gallegos
10:30 – 10:45 Ultrasound anatomy of dermal and subdermal venous plexus – A. Orrego 
10:45 – 11:00 Treatment of incompetent perforating veins with echosclerosis: Tips and tricks – V. Canata

ITALIAN SOCIETY OF LYMPHOANGIOLOGY & EUROPEAN SOCIETY OF LYMPHOLOGY & LATIN MEDITERRANEAN CHAPTER OF INTERNATIONAL SOCIETY OF LYMPHOLOGY

09:30 – 11:00 Lymphedema: Open questions and future prospectives Hall 2
Chairs: C. Campisi & S. Michelini
09:30 – 09:45 From the histopathology of lymphedema to the precise definition and staging – E. Fulcheri
09:45 – 10:00 The best practice for the combined physical treatment of lymphedema – S. Michelini
10:00 – 10:15 Clinical aspects – E. Dimakakos
10:15 – 10:30 Conservative treatment – M. Cestari
10:30 – 10:45 Surgical options – F. Boccardo
10:45 – 11:00 Staging-guided surgical approaches and amazing future directions – C. C. Campisi
11:00 – 11:30 TBC Hall 1
Chairs: TBC
11:00 – 11:30 Tailoring optimal antiplatelet therapies in vascular disease – J. Saucedo

PLENARY SESSION

11:30 – 13:00 An update on DOAC’s and vascular diseases Hall 1
Chairs: P. L. Antignani & J. Walenga
11:30 – 11:45 Current developments in teh expansion of the indications of DOACs – J. Fareed
11:45 – 12:00 DOACs in the management of acute coronary syndrome – E. Ramacciotti
12:00 – 12:15 DOACs in arterial diseases – K. Zorriasateyn
12:15 – 12:30 DOACs in cancer associated thrombosis – I. Elalamy
12:30 – 12:45 Neutralization of DOACs associated bleeding – J. Walenga
12:45 – 13:00 Developments in Xia inhibitors. Facts or fiction? – D. Hoppensteadt
13:00 Open discussion
13:00 – 13:30 Closing Ceremony Hall 1
Chairs: TBC